The Ability of Postimmunobiotics from
Lacticaseibacillus rhamnosus CRL1505
Streptococcus pneumoniae
TLR3
antiviral immunity
peptidoglycan
respiratory superinfection
respiratory syncytial virus
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
03 Nov 2022
03 Nov 2022
Historique:
received:
03
10
2022
revised:
26
10
2022
accepted:
02
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Previously, we demonstrated that the non-viable strain
Identifiants
pubmed: 36363777
pii: microorganisms10112185
doi: 10.3390/microorganisms10112185
pmc: PMC9694915
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agencia Nacional de Promoción Científica y Tecnológica
ID : PICT-2016-0410
Organisme : Japan Society for the Promotion of Science
ID : 19H00965
Références
Pediatr Res. 2005 Dec;58(6):1198-203
pubmed: 16306193
Cell. 2018 Nov 29;175(6):1634-1650.e17
pubmed: 30433869
Microorganisms. 2021 Mar 26;9(4):
pubmed: 33810287
J Immunol. 2012 Jan 15;188(2):811-7
pubmed: 22156592
Am J Respir Crit Care Med. 2014 Jul 15;190(2):196-207
pubmed: 24941423
Cells. 2020 Jul 09;9(7):
pubmed: 32660087
Microorganisms. 2019 Jun 06;7(6):
pubmed: 31174334
PLoS One. 2018 Mar 8;13(3):e0194034
pubmed: 29518131
Appl Environ Microbiol. 2019 Mar 6;85(6):
pubmed: 30683742
Vaccine. 2011 Oct 19;29(45):8002-11
pubmed: 21864623
Oncotarget. 2016 Apr 12;7(15):19327-40
pubmed: 27034012
Int Immunopharmacol. 2013 Oct;17(2):373-82
pubmed: 23838113
PLoS Pathog. 2013 Jan;9(1):e1003057
pubmed: 23326226
Antiviral Res. 2013 Mar;97(3):270-9
pubmed: 23274789
Nat Immunol. 2020 Feb;21(2):145-157
pubmed: 31932810
Sci Rep. 2021 Nov 4;11(1):21691
pubmed: 34737363
Probiotics Antimicrob Proteins. 2020 Sep;12(3):961-972
pubmed: 31630331
Microorganisms. 2020 Oct 26;8(11):
pubmed: 33114778
PLoS Pathog. 2018 Oct 10;14(10):e1007358
pubmed: 30304063
Front Immunol. 2017 Nov 27;8:1643
pubmed: 29230219
Front Immunol. 2020 Jan 23;11:15
pubmed: 32038659
Front Immunol. 2020 Sep 29;11:568636
pubmed: 33133080
Front Physiol. 2020 Jun 16;11:699
pubmed: 32670091
J Virol. 2006 Feb;80(4):1629-36
pubmed: 16439519
Methods Mol Biol. 2019;1887:131-144
pubmed: 30506255
Front Immunol. 2017 Aug 10;8:948
pubmed: 28848552
J Immunol. 2014 Jun 1;192(11):5265-72
pubmed: 24748495
Microorganisms. 2021 Jun 13;9(6):
pubmed: 34199284
BMC Immunol. 2013 Aug 15;14:40
pubmed: 23947615
Chest. 2013 Jul;144(1):39-47
pubmed: 23392627
Emerg Infect Dis. 2013 Jul;19(7):1084-91
pubmed: 23763864
PLoS One. 2016 Feb 12;11(2):e0146599
pubmed: 26872131
J Immunol. 2011 Jan 15;186(2):1151-61
pubmed: 21169550
Expert Rev Vaccines. 2020 Jan;19(1):57-70
pubmed: 31903805
Front Immunol. 2016 Dec 23;7:633
pubmed: 28066442
PLoS Pathog. 2013;9(11):e1003727
pubmed: 24244159
BMC Immunol. 2012 Sep 18;13:53
pubmed: 22989047
Microorganisms. 2021 Jun 18;9(6):
pubmed: 34207076
Expert Rev Vaccines. 2019 Jun;18(6):641-661
pubmed: 31230486
Mucosal Immunol. 2022 May;15(5):896-907
pubmed: 35856089
Int Immunopharmacol. 2011 Nov;11(11):1633-45
pubmed: 21708293
Int J Infect Dis. 2020 Mar;92:261-268
pubmed: 32147023
Front Immunol. 2020 Apr 08;11:543
pubmed: 32322251
Int Immunopharmacol. 2015 Apr;25(2):474-84
pubmed: 25744605
Epidemics. 2021 Jun;35:100444
pubmed: 33662812